168 related articles for article (PubMed ID: 30862396)
1. Consequences of hemolysis: Pro-inflammatory cytokine response to erythrophagocytosis.
Hod EA
Transfus Clin Biol; 2019 May; 26(2):125-127. PubMed ID: 30862396
[TBL] [Abstract][Full Text] [Related]
2. Clinical presentation of delayed hemolytic transfusion reactions and hyperhemolysis in sickle cell disease.
Fasano RM; Miller MJ; Chonat S; Stowell SR
Transfus Clin Biol; 2019 May; 26(2):94-98. PubMed ID: 30837199
[TBL] [Abstract][Full Text] [Related]
3. Red blood cell alloimmunization and delayed hemolytic transfusion reactions in patients with sickle cell disease.
Balbuena-Merle R; Hendrickson JE
Transfus Clin Biol; 2019 May; 26(2):112-115. PubMed ID: 30857806
[TBL] [Abstract][Full Text] [Related]
4. Delayed hemolytic transfusion reaction/hyperhemolysis syndrome in children with sickle cell disease.
Talano JA; Hillery CA; Gottschall JL; Baylerian DM; Scott JP
Pediatrics; 2003 Jun; 111(6 Pt 1):e661-5. PubMed ID: 12777582
[TBL] [Abstract][Full Text] [Related]
5. Challenges in preventing and treating hemolytic complications associated with red blood cell transfusion.
Chonat S; Arthur CM; Zerra PE; Maier CL; Jajosky RP; Yee MEM; Miller MJ; Josephson CD; Roback JD; Fasano R; Stowell SR
Transfus Clin Biol; 2019 May; 26(2):130-134. PubMed ID: 30979566
[TBL] [Abstract][Full Text] [Related]
6. Patrolling monocytes in sickle cell hemolytic conditions.
Liu Y; Zhong H; Vinchi F; Mendelson A; Yazdanbakhsh K
Transfus Clin Biol; 2019 May; 26(2):128-129. PubMed ID: 30898432
[TBL] [Abstract][Full Text] [Related]
7. The Red Blood Cell-Inflammation Vicious Circle in Sickle Cell Disease.
Nader E; Romana M; Connes P
Front Immunol; 2020; 11():454. PubMed ID: 32231672
[TBL] [Abstract][Full Text] [Related]
8. Anti-N and anti-Do
Unnikrishnan A; Pelletier JPR; Bari S; Zumberg M; Shahmohamadi A; Spiess BD; Michael MJ; Harris N; Harrell D; Mandernach MW
Transfusion; 2019 Jun; 59(6):1907-1910. PubMed ID: 30768787
[TBL] [Abstract][Full Text] [Related]
9. Complement activation during intravascular hemolysis: Implication for sickle cell disease and hemolytic transfusion reactions.
Merle NS; Boudhabhay I; Leon J; Fremeaux-Bacchi V; Roumenina LT
Transfus Clin Biol; 2019 May; 26(2):116-124. PubMed ID: 30879901
[TBL] [Abstract][Full Text] [Related]
10. Multiple hemolytic transfusion reactions misinterpreted as severe vaso-occlusive crisis in a patient with sickle cell disease.
Dean CL; Maier CL; Roback JD; Stowell SR
Transfusion; 2019 Feb; 59(2):448-453. PubMed ID: 30412270
[TBL] [Abstract][Full Text] [Related]
11. CXCL1 and its receptor, CXCR2, mediate murine sickle cell vaso-occlusion during hemolytic transfusion reactions.
Jang JE; Hod EA; Spitalnik SL; Frenette PS
J Clin Invest; 2011 Apr; 121(4):1397-401. PubMed ID: 21383500
[TBL] [Abstract][Full Text] [Related]
12. Management of delayed hemolytic transfusion reaction in sickle cell disease: Prevention, diagnosis, treatment.
Pirenne F; Bartolucci P; Habibi A
Transfus Clin Biol; 2017 Sep; 24(3):227-231. PubMed ID: 28669521
[TBL] [Abstract][Full Text] [Related]
13. The role of Complement in Post-Transfusion Hemolysis and Hyperhemolysis Reaction.
Roumenina LT; Bartolucci P; Pirenne F
Transfus Med Rev; 2019 Oct; 33(4):225-230. PubMed ID: 31672341
[TBL] [Abstract][Full Text] [Related]
14. Role of Macrophages in Sickle Cell Disease Erythrophagocytosis and Erythropoiesis.
Sesti-Costa R; Costa FF; Conran N
Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047304
[TBL] [Abstract][Full Text] [Related]
15. Sickle Cell Trait Increases Red Blood Cell Storage Hemolysis and Post-Transfusion Clearance in Mice.
Osei-Hwedieh DO; Kanias T; Croix CS; Jessup M; Xiong Z; Sinchar D; Franks J; Xu Q; M Novelli E; Sertorio JT; Potoka K; Binder RJ; Basu S; Belanger AM; Kim-Shapiro DB; Triulzi D; Lee JS; Gladwin MT
EBioMedicine; 2016 Sep; 11():239-248. PubMed ID: 27523807
[TBL] [Abstract][Full Text] [Related]
16. Immuno-hematological findings in Delayed Hemolytic Transfusion Reaction (DHTR).
Thonier V
Transfus Clin Biol; 2019 May; 26(2):102-108. PubMed ID: 30885514
[TBL] [Abstract][Full Text] [Related]
17. Cytokine changes in sickle-cell disease patients as markers predictive of the onset of delayed hemolytic transfusion reactions.
Chadebech P; de Ménorval MA; Bodivit G; Jouard A; Pakdaman S; Lelong F; Habibi A; Galactéros F; Lecron JC; Pirenne F
Cytokine; 2020 Dec; 136():155259. PubMed ID: 32920319
[TBL] [Abstract][Full Text] [Related]
18. Macrophages clear refrigerator storage-damaged red blood cells and subsequently secrete cytokines in vivo, but not in vitro, in a murine model.
Wojczyk BS; Kim N; Bandyopadhyay S; Francis RO; Zimring JC; Hod EA; Spitalnik SL
Transfusion; 2014 Dec; 54(12):3186-97. PubMed ID: 25041478
[TBL] [Abstract][Full Text] [Related]
19. Red blood cell alloimmunization is influenced by recipient inflammatory state at time of transfusion in patients with sickle cell disease.
Fasano RM; Booth GS; Miles M; Du L; Koyama T; Meier ER; Luban NL
Br J Haematol; 2015 Jan; 168(2):291-300. PubMed ID: 25256676
[TBL] [Abstract][Full Text] [Related]
20. Featured Article: Depletion of HDL
Soupene E; Larkin SK; Kuypers FA
Exp Biol Med (Maywood); 2017 Jun; 242(12):1244-1253. PubMed ID: 28436274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
